tiprankstipranks
Trending News
More News >
Passage Bio (PASG)
NASDAQ:PASG
US Market

Passage Bio (PASG) Financial Statements

Compare
645 Followers

Passage Bio Financial Overview

Passage Bio's market cap is currently $47.30M. The company's EPS TTM is $-2.44; its P/E ratio is -0.99; Passage Bio is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is $-2.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -3.72M$ 0.00$ 0.00$ 0.00
Operating Income$ -70.40M$ -100.14M$ -138.39M$ -185.73M$ -112.90M
EBITDA$ -62.09M$ -98.34M$ -131.72M$ -176.19M$ -111.10M
Net Income$ -64.77M$ -102.06M$ -136.13M$ -185.39M$ -112.23M
Balance Sheet
Cash & Short-Term Investments$ 76.76M$ 114.29M$ 189.61M$ 315.77M$ 304.82M
Total Assets$ 102.41M$ 150.54M$ 243.55M$ 355.08M$ 328.01M
Total Debt$ 25.48M$ 26.29M$ 27.11M$ 0.00$ 0.00
Net Debt$ -12.10M$ 4.58M$ -7.49M$ -128.97M$ -135.00M
Total Liabilities$ 41.15M$ 39.26M$ 42.18M$ 36.42M$ 23.29M
Stockholders' Equity$ 61.26M$ 111.28M$ 201.37M$ 318.66M$ 304.71M
Cash Flow
Free Cash Flow$ -47.99M$ -78.41M$ -123.48M$ -152.52M$ -82.17M
Operating Cash Flow$ -47.96M$ -78.26M$ -118.21M$ -126.88M$ -80.52M
Investing Cash Flow$ 54.95M$ 65.24M$ 25.20M$ -45.81M$ -172.11M
Financing Cash Flow$ 8.87M$ 135.00K$ -1.35M$ 166.66M$ 228.75M
Currency in USD

Passage Bio Earnings and Revenue History

Passage Bio Debt to Assets

Passage Bio Cash Flow

Passage Bio Forecast EPS vs Actual EPS